Targeted Genetics appoints new president and CEO
This article was originally published in Scrip
Targeted Genetics (US) has appointed Susan Robinson president and chief executive officer following the resignation of Stewart Parker. Dr Barrie Carter has also resigned as executive vice-president and chief scientific officer. Ms Robinson joined Targeted Genetics in March 2000 and previously served as vice-president of business development.
You may also be interested in...
Recent moves show Chinese biotech firms are increasingly looking to go global by recruiting world-class development talent, and J&J names new APAC pharma head.
Janet Woodcock’s 2019 prediction that record ANDA approval volumes would not continue is confirmed with the FY 2020 approval total down 21% from the previous year.
Deal snapshot: Resolving a loose end from its 2014 buyout of Auxilium, Endo acquires all rights to Xiaflex, along with approved cellulite therapy Qwo.